Brain

Formula Wellness Partners with Bella Excellence to Elevate Wellness and Aesthetics in Tampa Bay

DALLAS, TX / ACCESS Newswire / January 21, 2025 / Formula Wellness, a pioneer in personalized health and wellness solutions,…

1 year ago

NXR Partners with Emotiv to Launch Revolutionary Emotional Heat-mapping Technology

This collaboration merges advanced analytics with EEG technology for next-level emotional insights CAMBRIDGE, England, Jan. 21, 2025 /PRNewswire/ -- Neuro…

1 year ago

AIRS Medical Partners with Starvision to Bring SwiftMR® MRI Technology to Radiology Practices Throughout Germany

SEOUL, South Korea, Jan. 21, 2025 /PRNewswire/ -- AIRS Medical has finalized a landmark agreement with Starvision, a leading radiological…

1 year ago

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology…

1 year ago

Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development…

1 year ago

Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®

Operations Leader to Enhance Operational Efficiencies by Managing Production Scale-up and Cost Reduction Activities to Support CommercializationBRAINTREE, Mass., Jan. 21,…

1 year ago

Nascent Biotech Receives Delinquency Notification Related to its Delayed September 30, 2024 Financial Filing

NORTH PALM BEACH, FL, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”),…

1 year ago

Oragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO

SARASOTA, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for…

1 year ago

Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target

--128 enrolled participants, as of December 31, 2024, exceeds initial target of 90 participants-- --150 maximum participant enrollment projected by…

1 year ago